Bioworkshops sell "Imdevimab"
Basic Information
810
24
19
4.4(36)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Imdevimab
Manufacturer(s)
Specifications
- Regulatory Status: Monoclonal antibody targeting the SARS-CoV-2 spike protein; reference product originated by Regeneron Pharmaceuticals and first approved in the United States on 21 November 2020
- Application: Used in infectious/respiratory disease settings, with COVID-19 as the representative indication
- Formulation Type: Developed from a DMF-filed, high-titer optimized cell line with analytical comparability to the reference product, supporting biosimilar development
Documents
GMP
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment